✦ LIBER ✦

Correction regarding an adverse reaction to the recombinant hepatitis B vaccine

✍ Scribed by HUDSON, T; SHUSTER, J; TEUWEN, D; PEETERMANS, J

Book ID: 119061368
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 104 KB
Volume: 92
Category: Article
ISSN: 1097-6825
DOI: 10.1016/0091-6749(93)90134-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adverse reaction to the recombinant hepa

Adverse reaction to the recombinant hepatitis B vaccine

✍ Hudson, Thomas James; Newkirk, Marianna; Gervais, Francine; Shuster, Joseph 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 470 KB

Major adverse reactions to yeast-derived

Major adverse reactions to yeast-derived hepatitis B vaccines—a review

✍ I. Grotto; Y. Mandel; M. Ephros; I. Ashkenazi; J. Shemer 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 902 KB

Frequency of adverse reactions to hepati

Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons

✍ Brian J. McMahon; Claire Helminiak; Robert B. Wainwright; Lisa Bulkow; Brian A. 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 391 KB

The Response of Isolated Anti-HBc Positi

The Response of Isolated Anti-HBc Positive Subjects to Recombinant Hepatitis B Vaccine

✍ O. Ural; D. Findik 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Comparative Safety of Two Recombinant He

Comparative Safety of Two Recombinant Hepatitis B Vaccines in Children: Data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD)

✍ Manette T. Niu; Philip Rhodes; Marcel Salive; Thomas Lively; David M. Davis; Ste 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 199 KB

Diminished response to recombinant hepat

Diminished response to recombinant hepatitis B vaccine in homosexual men with HIV antibody: An indicator of poor prognosis

✍ Richard H. T. Loke; Dr. Iain M. Murray-Lyon; John C. Coleman; Brian A. Evans; Ar 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB

## Abstract Three doses of a recombinant DNA HBV vaccine (MSD) were given to healthy male homosexuals. Seventy‐eight out of 104 (77.6%) participants had detectable antibody (anti‐HBs) two months after the third dose. Seroconversion occurred in only 9 out of 27 subjects (33.3%) who were anti‐HIV pos